New research partly led by UCSF-affiliated scientists suggests that one in 10 cancer patients would be more accurately diagnosed if their tumors were defined by cellular and molecular criteria rather than by the tissues in which they originated.
August 07, 2014
July 15, 2014
UCSF Medical Center is among the nation's premier hospitals for the 13th consecutive year, ranking as the eighth best hospital in the country according to U.S. News & World Report.
May 07, 2014
Screening for cervical cancer has become more complex in the last few years, leaving physicians and patients in a quandary: do they test with the traditional Pap smear or do they add a test for human papilloma virus? UCSF ob/gyn Karen Smith-McCune, MD, PhD, weighs in.
April 01, 2014
Doctors should focus on life expectancy when deciding whether to order mammograms for their oldest female patients, since the harms of screening likely outweigh the benefits unless women are expected to live at least another decade, according to a review of the scientific literature by experts at UCSF and Harvard medical schools.
March 17, 2014
One of the world’s preeminent cancer scientists, Alan Ashworth, PhD, FRS, has been appointed the new director of the UCSF Helen Diller Family Comprehensive Cancer Center.
February 05, 2014
CVS Caremark, the nation’s largest pharmacy health care company, and UCSF's Steven Schroeder say selling tobacco products is “clearly antithetical” to the role of pharmacies.
February 04, 2014
Researchers are harnessing the power of the body's natural defenses to fight deadly cancers, and the treatment appears to be powerful, effective and long-lasting.
December 18, 2013
Experts across UCSF weigh in on what some of 2014's top trends are in research and patient care.
December 05, 2013
UCSF has been awarded a major federal grant to “transform and revolutionize” the treatment of prostate cancer, the second most common form of cancer among American men.
October 16, 2013
A UCSF-led team of scientists has discovered that a gene mutation found in some bladder cancers is indicative of low-risk tumors that are unlikely to recur or progress after surgery.